During the past decade, SZTE ÁOK Szent Györgyi Albert Klinikai Kozpont conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 4 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 4 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SZTE ÁOK Szent Györgyi Albert Klinikai Kozpont" #1 sponsor was "Bayer" with 11 trials, followed by "Applied Molecular Transport" with 1 trials sponsored, "Cardionomic Inc." with 1 trials sponsored, "Guerbet" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SZTE ÁOK Szent Györgyi Albert Klinikai Kozpont" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "Population Health Research Institute" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "SZTE ÁOK Szent Györgyi Albert Klinikai Kozpont" are "Chronic Kidney Disease" (2 trials), "Endometriosis" (2 trials), "Acute Decompensated Heart Failure" (1 trials), "Acute Non-cardioembolic Ischemic Stroke" (1 trials) and "Alopecia Areata" (1 trials). Many other conditions were trialed in "SZTE ÁOK Szent Györgyi Albert Klinikai Kozpont" in a lesser frequency.

Most popular intervention types in "SZTE ÁOK Szent Györgyi Albert Klinikai Kozpont" are "Drug" (14 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "AMT-101 (oral)-Dose A" (1 trials), "AMT-101 (oral)-Dose B" (1 trials), "Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)" (1 trials) and "Aflibercept VEGF Trap-Eye (Eylea, BAY86-5321)" (1 trials). Other intervention names were less common.

The vast majority of trials in "SZTE ÁOK Szent Györgyi Albert Klinikai Kozpont" are 12 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "SZTE ÁOK Szent Györgyi Albert Klinikai Kozpont". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in SZTE ÁOK Szent Györgyi Albert Klinikai Kozpont, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in SZTE ÁOK Szent Györgyi Albert Klinikai Kozpont, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".